Initiation of guideline-matched oral anticoagulant in atrial fibrillation-related stroke
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Eun, M.-Y. | - |
dc.contributor.author | Kim, J.-Y. | - |
dc.contributor.author | Hwang, Y.-H. | - |
dc.contributor.author | Park, M.-S. | - |
dc.contributor.author | Kim, J.-T. | - |
dc.contributor.author | Choi, K.-H. | - |
dc.contributor.author | Jung, J.-M. | - |
dc.contributor.author | Yu, S. | - |
dc.contributor.author | Kim, C.K. | - |
dc.contributor.author | Oh, K. | - |
dc.contributor.author | Song, T.-J. | - |
dc.contributor.author | Kim, Y.-J. | - |
dc.contributor.author | Kim, B.J. | - |
dc.contributor.author | Heo, S.H. | - |
dc.contributor.author | Park, K.-Y. | - |
dc.contributor.author | Kim, J.-M. | - |
dc.contributor.author | Park, J.-H. | - |
dc.contributor.author | Choi, J.C. | - |
dc.contributor.author | Chung, J.-W. | - |
dc.contributor.author | Bang, O.Y. | - |
dc.contributor.author | Kim, G.-M. | - |
dc.contributor.author | Seo, W.-K. | - |
dc.date.accessioned | 2021-12-04T21:00:16Z | - |
dc.date.available | 2021-12-04T21:00:16Z | - |
dc.date.created | 2021-08-31 | - |
dc.date.issued | 2021-01 | - |
dc.identifier.issn | 2287-6391 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/129446 | - |
dc.description.abstract | Background and Purpose To evaluate the outcome events and bleeding complications of the European Society of Cardiology (ESC) guideline-matched oral anticoagulant therapy for patients with acute ischemic stroke and atrial fibrillation (AF). Methods Patients with acute ischemic stroke and AF from a nationwide multicenter registry (Kore-an ATrial fibrillaTion EvaluatioN regisTry in Ischemic strOke patieNts [K-ATTENTION]) between January 2013 and December 2015 were included in the study. Patients were divided into the ESC guide-line-matched and the non-matched groups. The primary outcome was recurrence of any stroke during the 90-day follow-up period. Secondary outcomes were major adverse cerebrovascular and cardiovascular events, ischemic stroke, intracranial hemorrhage, acute coronary syndrome, all-cause mortality, and major hemorrhage. Propensity score matching and logistic regression analyses were performed to assess the effect of the treatments administered. Results Among 2,321 eligible patients, 1,126 patients were 1:1 matched to the ESC guideline-matched and the non-matched groups. As compared with the non-matched group, the ESC guide-line-matched group had a lower risk of any recurrent stroke (1.4% vs. 3.4%; odds ratio [OR], 0.41; 95% confidence interval [CI], 0.18 to 0.95). The risk of recurrent ischemic stroke was lower in the ESC guideline-matched group than in the non-matched group (0.9% vs. 2.7%; OR, 0.32; 95% CI, 0.11 to 0.88). There was no significant difference in the other secondary outcomes between the two groups. Conclusions ESC guideline-matched oral anticoagulant therapy was associated with reduced risks of any stroke and ischemic stroke as compared with the non-matched therapy. © 2021 Korean Stroke Society. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Stroke Society | - |
dc.title | Initiation of guideline-matched oral anticoagulant in atrial fibrillation-related stroke | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jung, J.-M. | - |
dc.identifier.doi | 10.5853/jos.2020.03440 | - |
dc.identifier.scopusid | 2-s2.0-85101185783 | - |
dc.identifier.wosid | 000672470600010 | - |
dc.identifier.bibliographicCitation | Journal of Stroke, v.23, no.1, pp.113 - 123 | - |
dc.relation.isPartOf | Journal of Stroke | - |
dc.citation.title | Journal of Stroke | - |
dc.citation.volume | 23 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 113 | - |
dc.citation.endPage | 123 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002682296 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | ISCHEMIC-STROKE | - |
dc.subject.keywordAuthor | Anticoagulants | - |
dc.subject.keywordAuthor | Atrial fibrillation | - |
dc.subject.keywordAuthor | Guideline | - |
dc.subject.keywordAuthor | Outcome | - |
dc.subject.keywordAuthor | Stroke | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.